Arun Upadhyay

Company: Ocugen

Job title: Chief Scientific Officer

Bio:

Arun Upadhyay, PhD, Chief Scientific Officer, and Head of Research, Development and Medical, drives Ocugen’s innovation and product development. He leads science and operations, creating and implementing fit-for-purpose strategies that enable scientific and business solutions. He oversees the development of various product modalities, such as biologics, vaccines, cell and gene therapy, and regenerative medicine and is responsible for all product development activities including discovery, proof of concept, preclinical, bioanalyses, CMC, clinical, safety, medical support, and global regulatory submissions across entire R&D pipeline.

Seminars:

Advancements in Gene Therapy for Ophthalmic Disorders: Ocugen’s Clinical Program Updates 11:30 am

Advancing the transition from preclinical to clinical stages and a gene-agnostic trial approach for diverse patient recruitment Optimizing the enrolment progress and Phase 3 developments for Leber Congenital Amaurosis (LCA) Uncovering the safety profile and efficacy data for Dry Age-Related Macular Degeneration (AMD) programRead more

day: Day Two 12th

Navigating Regulatory Pathways for Ophthalmic Gene Therapies 1:00 pm

With the evolving landscape of gene therapy and regulatory frameworks, understanding and effectively navigating regulatory pathways are crucial for the development and approval of ophthalmic gene therapies. This workshop provides insights into regulatory challenges, collaboration strategies, and innovative approaches to accelerate the approval process for breakthrough ocular gene therapies. Key Discussion Points: Regulatory Landscape Overview:…Read more

day: Pre-Conference Workshop Day Clinical Track PM